Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Brain Metastases
Related studies linked through entity extraction aliases.
SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Brigatinib Before Brain Irradiation Trial (B3i Trial)
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Analyzing Preoperative Stereotactic Radiosurgery With Gamma Knife Icon for Brain Metastases
- Status
- COMPLETED
- Phase
- NA
Dosimetric Validation of Scans Generated by GAN From Pre-therapeutic MRI in Stereotactic Cerebral Radiotherapy
- Status
- COMPLETED
- Phase
- N/A
TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Stereotactic Radiosurgery for Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Pre- Versus Post-operative SRS for Resectable Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE3
Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
- Status
- COMPLETED
- Phase
- PHASE1
Single vs Multi-fraction SRS Patients on Immunotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Preoperative SRS/SRT vs Postoperative SRS/SRT for Brain Metastases
- Status
- TERMINATED
- Phase
- NA
DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
- Status
- COMPLETED
- Phase
- PHASE2
X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE3